Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals-Broader/General Applications

Investigating the potential of Cu-64-annexin V as an imaging agent for cell death

Oluwatayo Ikotun and Suzanne Lapi
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1456;
Oluwatayo Ikotun
1Radiological Sciences, Washington University School of Medicine, Saint Louis, MO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne Lapi
1Radiological Sciences, Washington University School of Medicine, Saint Louis, MO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1456

Objectives Annexin V is a calcium-dependent glycoprotein, that has been shown to detect apoptosis by binding to the membrane-bound phosphatidylserine (PS), an anionic phospholipid, with nanomolar affinity (Kd = 7 nmol). PS is normally confined to the inner leaflet of the plasma membrane and the exposure of PS on the cell’s outer surface occurs in the early stages of apoptosis. The ability to monitor apoptosis in association with disease progression or regression would be clinically relevant. Thus, we plan to optimize the synthesis of the positron emission tomography (PET) imaging agent, copper-64-DOTA-annexin V, investigate structural changes, and determine affinity and binding to PS in vitro.

Methods We synthesized, purified, and characterized copper-64-DOTA-annexin V. We studied the chemical purity by high pressure liquid chromatography, characterized by MALDI-TOF, and investigated structural changes and thermal denaturing via fluorescence and circular dichorism studies respectively. Lastly we explored the potential of copper-64-DOTA-annexin V to detect treatment-induced apoptosis in colorectal carcinoma cells, HCT-116.

Results The imaging agent, copper-64-DOTA-annexin V was successfully synthesized and purified. Structural changes to Annexin V were observed upon inclusion of the chelating agent, DOTA. Copper-64-DOTA-annexin V was shown to recognize PS and detect treatment-induced apoptosis in HCT 116 cells.

Conclusions The inclusion DOTA to annexin V resulted in structural changes to the protein and potentially results in the exposure of tryptophan residues that were previously embedded. Despite these changes, copper-64-DOTA-annexin V was shown to bind to PS with high affinity, and was sensitive to treatment-induced apoptosis

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Investigating the potential of Cu-64-annexin V as an imaging agent for cell death
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Investigating the potential of Cu-64-annexin V as an imaging agent for cell death
Oluwatayo Ikotun, Suzanne Lapi
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1456;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Investigating the potential of Cu-64-annexin V as an imaging agent for cell death
Oluwatayo Ikotun, Suzanne Lapi
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1456;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Broader/General Applications

  • Optimization of 11C-Donepezil radiosynthesis to study pharmacokinetics of reversible acetylcholine esterase inhibitor
  • Chemokine receptor inhibition alters 111In-leukocyte trafficking in normal rats
  • 125I-Labeled gold nanorods and biodistribution
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Broader/General Applications

New Radiopharmaceuticals-Broader/General Applications Posters

  • Automated radiosynthesis of [11C]CH3Br as a new radioprecursor for methylation reaction
  • Design and performance of a novel 5 mCi 44T/44Sc-radionuclide generator
  • Chemokine receptor inhibition alters 111In-leukocyte trafficking in normal rats
Show more New Radiopharmaceuticals-Broader/General Applications Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire